Navigation Links
Boston Scientific Launches PROMUS® Element™ and TAXUS® Element™ Stent Systems in India
Date:2/17/2011

of patients worldwide – on an entirely new platform," said Hank Kucheman, Executive Vice President and Group President, Cardiology, Rhythm and Vascular for Boston Scientific.  "The PtCr Element System highlights our commitment to DES market leadership and continued innovation for physicians and their patients."  

"A key component of our growth strategy involves expanding our footprint in emerging markets like India, where we are making significant investments in sales, distribution and clinical infrastructure," said Ray Elliott, President and Chief Executive Officer of Boston Scientific.  "Our PtCr stent technology platform provides a significant advantage in this fast-growing market."

The PROMUS Element Stent is being evaluated in the PLATINUM clinical trial, which completed enrollment of 1,532 patients in September 2009 at more than 140 sites worldwide.  PLATINUM is a randomized, controlled, pivotal trial designed to support U.S. Food and Drug Administration (FDA) and Japanese Ministry of Health, Labor and Welfare (MHLW) approval of the PROMUS Element Stent System.  In September 2010, data were presented on 30-day and nine-month clinical outcomes and nine-month quantitative coronary angiography (QCA) and intravascular ultrasound (IVUS) supporting the safety and efficacy of the PROMUS Element Stent.

The TAXUS Element Stent is being evaluated in the PERSEUS trial, which reported 12-month results in March 2009, demonstrating positive safety and efficacy outcomes in workhorse lesions for the TAXUS Element Stent System compared to the TAXUS® Express2® Stent System.  The PERSEUS clinical program compared the TAXUS Element Stent to prior-generation Boston Scientific stents in more than 1,600 patients in two parallel trials at 90 centers worldwide.

The Company received CE Mark for the PROMUS Element Everolimus-Eluting Stent System in October 2009 and for the TAXUS Element Pacl
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Boston Scientific to Participate in 2011 RBC Capital Markets Healthcare Conference
2. Boston Scientific Acquires Two Novel Technologies to Treat Peripheral Chronic Total Occlusions
3. Boston Scientific Establishes Endowment for Donald S. Baim, M.D., Scholarship at Yale School of Medicine
4. Boston Scientific Welcomes Publication of Gender Data Highlighting Benefits Women Receive From CRT-Ds
5. Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010
6. Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System
7. Boston Scientific Responds to DOJ Civil Lawsuit
8. Boston Scientific Announces First Use of Blazer® Open-Irrigated Catheter in U.S.
9. Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Element™ Everolimus-Eluting Stent
10. Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent
11. Boston Scientific Announces Agreement With Fukuda Denshi for Distribution of Cardiac Rhythm Management Products in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... VEGAS , Sept. 1, 2015  Dr. ... DigiPath Labs , the cannabis testing subsidiary of DigiPath, ... Patients Group about the lack of consistency in ... the online resource for medical cannabis information, she explained ... patients because their lack of uniform requirements makes standardization ...
(Date:9/1/2015)... 2015   Millstone Medical Outsourcing announced today that ... Olive Branch, MS. Now totaling over ... facility has added the capacity required to meet the high ... expansion gives us the opportunity to grow in parallel with ... MS. "Two and a half years ago we were operating ...
(Date:9/1/2015)... 2015   Ivenix Inc. , a medical ... closed on a $42M round of equity financing ... Partners, CICA, Inc., Easterly Capital, Fidelity Biosciences, and ... This financing will support the company,s efforts to ... LLC acted as the exclusive placement agent for ...
Breaking Medicine Technology:DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 2DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 3Millstone Medical Outsourcing Announces Olive Branch Expansion 2Ivenix Inc. Secures $42 Million in Funding 2Ivenix Inc. Secures $42 Million in Funding 3
... Second generation,pyridopyrazine-urea derivative compound series show highly,selective ... , , QUBEC CITY, Canada, April,16, ... Nasdaq:,AEZS), a global, pure play biopharmaceutical company ... an abstract,outlining first in vitro data on ...
... Activity as Vascular Disrupting Agent and,Tubulin Inhibitor ... 2007—Myriad Genetics, Inc.,(NASDAQ: MYGN) (<a target="_blank" href=,"http://www.myriad.com/">www.myriad.com ... characterize the mode of action of its,investigational ... at the annual meeting of the American ...
Cached Medicine Technology:terna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 2terna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 3terna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 4Myriad Genetics Presents Azixa's Mode of Action at AACR 2Myriad Genetics Presents Azixa's Mode of Action at AACR 3
(Date:9/1/2015)... ... September 01, 2015 , ... An ... of thousands of plastic surgeries conducted each year on teenagers, quoting a New ... growing numbers. Beverly Hills-based plastic surgeon Payam Jarrah-Nejad, M.D., F.I.C.S., F.A.C.S., known more ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... explained how many dental practices across the country are switching from traditional dental ... to Beverly Hills cosmetic dentist Dr. Sam Saleh of Ora Dentistry Spa, his ...
(Date:9/1/2015)... ... September 01, 2015 , ... Earth Brands, ( http://www.earthbrands.com ) ... Every customer who buys an Earth Brand shoe will be given an opportunity ... for the Future, a nonprofit dedicated to planting more trees. Earth Brands products ...
(Date:9/1/2015)... ... September 01, 2015 , ... The Lymphoma ... innovative lymphoma research and serving the lymphoma community through a comprehensive series of ... it Red for Lymphoma awareness initiative, the nation’s premier and most high-profile lymphoma ...
(Date:9/1/2015)... ... September 01, 2015 , ... From Aug. 17-21, Calvary ... teenagers, from ages 6-18. Calvary’s Camp Compass® has taken place at Kingsborough Community College ... adult counselors, some of whom work for Calvary, and two junior counselors who were ...
Breaking Medicine News(10 mins):Health News:Teen Plastic Surgery Article Understates the Most Important Realities of Procedures on Young People, Notes Dr. J 2Health News:Article on CAD/CAM Dental Technology Highlights the Advantages of 21st Century Dentistry, Notes Ora Dentistry Spa 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 3Health News:Lymphoma Research Foundation Recognizes National Blood Cancer Awareness Month with Light it Red for Lymphoma Campaign 2Health News:Lymphoma Research Foundation Recognizes National Blood Cancer Awareness Month with Light it Red for Lymphoma Campaign 3Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3
... Compounded Hormones, WASHINGTON, Feb. 12 ... called on the American,Association of Clinical Endocrinologists ... to fully disclose their financial ties to ... that directly benefits,the pharmaceutical giant. In recent ...
... 12 TeamStaff, Inc.,(Nasdaq: TSTF ) ... services, announced today that it is changing ... Staffing Services, Inc., to TeamStaff,Government Solutions (dba ... subsidiary currently provides medical, office,administration and logistics ...
... families may have underlying speech deficits , , TUESDAY, ... or family history of learning disabilities may be more ... causes them to lose language abilities as they age, ... known as primary progressive aphasia, causes language abilities to ...
... YUCAIPA, Calif., Feb. 12 Ingen Technologies,Inc. (OTC ... the signed distribution agreement with Progressive International,Holding Co. ... Taiwan, People,s,Republic of China, Japan and Korea. Please ... Progressive International Holding Company (PIHK),( http://www.pgiholding.com ) and ...
... announcement by,the United States Food and Drug Administration that ... toxin type A), customers are,looking for alternatives to treat ... in 2002 for the temporary treatment of,moderate to severe ... 65 years,of age. In its recent communication, the FDA ...
... Feb. 12 Iomai Corporation,(Nasdaq: IOMI ) today ... the second dose of the two-dose regimen for its ... when,self-applied by subjects outside of a clinical setting., ... program for the,vaccine, measured the immune response to the ...
Cached Medicine News:Health News:American Association of Clinical Endocrinologists and North American Menopause Society Fail to Disclose Financial Ties to Wyeth Pharmaceuticals 2Health News:TeamStaff Renames Subsidiary to Reflect Expanding Government Services 2Health News:TeamStaff Renames Subsidiary to Reflect Expanding Government Services 3Health News:Learning Disabilities May Presage Later Language Problems 2Health News:Ingen Technologies Brings Oxyview(R) to Asia Through Major Medical Distributor 2Health News:Ingen Technologies Brings Oxyview(R) to Asia Through Major Medical Distributor 3Health News:Botox Cosmetic Alternatives Are Available: Surgical Procedures Offer Solution for Wrinkles 2Health News:Iomai Study Shows Self-Applied Travelers' Diarrhea Vaccine Patch Comparable to Clinician-Applied Vaccine Patch 2Health News:Iomai Study Shows Self-Applied Travelers' Diarrhea Vaccine Patch Comparable to Clinician-Applied Vaccine Patch 3Health News:Iomai Study Shows Self-Applied Travelers' Diarrhea Vaccine Patch Comparable to Clinician-Applied Vaccine Patch 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: